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Summary 
Whether protein synthesis and cellular stress response pathways interact to control stem 
cell function is currently unknown. Here, we show that skin stem cells synthesize less 
protein than their immediate progenitors in vivo, even when forced to proliferate. Our 
analyses reveal that activation of stress response pathways drives both a global 
reduction of protein synthesis and altered translational programmes that together 
promote stem cell functions and tumourigenesis. Mechanistically we show that 
inhibition of post-transcriptional cytosine-5 methylation locks stem cells in this distinct 
translational inhibition programme. Paradoxically, this inhibition renders stem cells 
hypersensitive to cytotoxic stress, as tumour regeneration after treatment with 5-
fluorouracil is blocked. Thus, stem cells must revoke translation inhibition pathways to 
regenerate a tissue or tumour.  
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Introduction 
Protein synthesis is a fundamental process for all cells, but its precise regulatory roles 
in development, stem cells, and cancer are not well understood. We recently identified 
post-transcriptional methylation of transfer RNA (tRNA) at cytosine-5 (m5C) by 
NSun2 as a novel mechanism to repress global protein synthesis1,2. Loss of NSun2 
causes hypo-methylation of tRNAs, allowing endonucleolytic cleavage by angiogenin 
and accumulation of 5’ tRNA fragments1,3. These fragments repress cap-dependent 
protein translation4-7.  
 
Correct RNA methylation is essential for development and tissue homeostasis. Loss-
of-function mutations in human NSUN2 cause growth retardation and neuro-
developmental defects including microcephaly1,8-10. In mouse, NSun2-associated 
microcephaly can be rescued by inhibiting angiogenin-mediated tRNA-cleavage1. In 
adult tissues (testis and skin), NSun2 is only expressed in a sub-population of 
committed progenitors, where its activity balances self-renewal and differentiation11,12.  
 
Here, we reveal that the interplay between RNA methylation and translation shapes 
stem cell fate. Using skin as a model, we demonstrate that stem cells have lower protein 
synthesis than committed cells in both homeostasis and tumourigenesis. Low 
translation functionally contributes to maintain stem cells, and is not merely a 
consequence of quiescence or cell cycle state. By genetically deleting NSun2 in a 
tumour mouse model, we find that protein synthesis is globally repressed; however, 
distinct transcripts escape this repression and establish a translational programme 
crucial to stimulate stem cell functions. Unexpectedly, the selective alteration of 
translation is remarkably effective in rendering stem cells sensitive to cytotoxic stress. 
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Results 
Stem cells synthesize less protein than their progeny 
In skin, the best-characterized stem cell populations reside in the hair follicle13. Hair 
follicle stem cells (HFSC) are periodically activated at the onset of hair growth 
(anagen), which is followed by phases of regression (catagen) and rest (telogen) 
(Extended Data Fig. 1a)14,15. HFSCs located in the bulge (BG) express the stem cell 
markers CD34, keratin-19 (K19) and Lgr5 (Fig. 1a)16,17.  
 
To visualize HFSCs and their progeny, we genetically labeled K19- and Lgr5-
expressing bulge stem cells with a tdTomato (tdTom) reporter (Fig. 1a,b; Extended 
Data Fig. 1a)16,18. To measure global protein synthesis we quantified incorporation of 
OP-puromycin (OP-puro) into nascent proteins (Fig. 1b)19. Protein synthesis was 
uniformly low in the interfollicular epidermis (IFE), but highly dynamic in hair follicles 
throughout the hair cycle (Extended Data Fig. 1b). In telogen, highly translating cells 
at the follicle base were not stem cells, as they were negative for tdTomato (Fig. 1c,d; 
Extended Data Fig. 1c). In late anagen, OP-puro co-localized with tdTomato in 
committed progenitors located in the hair bulb (Fig. 1e,f; Extended Data Fig. 1d; 
arrows). The highest translation was displayed above the hair matrix, which contains 
committed progenitors that divide a finite number of times before differentiating (Fig. 
1e,f; Extended Data Fig. 1d; arrowheads)20. 
 
Co-labeling of OP-puro with markers for all hair lineages identified the Henle’s (He) 
and Huxley’s (Hu) layers of the inner root sheath (IRS) as the lineages with highest 
translation (Fig. 1g-k; Extended Data Fig. 1e,f)21,22. Both IRS layers exclusively contain 
committed and differentiated cells22.  
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To fully quantify protein synthesis in distinct epidermal populations, we flow-sorted 
bulge stem cells (CD34+/6+), non-bulge cells (CD34-/6+), and differentiated cells 
(CD34-/6-) (Fig. 2a-c)17. To capture epidermal cells giving rise to the highly 
translating IRS, we enriched for OP-purohigh cells (top 2.5% in rate of translation) (Fig. 
2b). The selection for high translation did not perturb the proportion of cell populations 
found in the epidermis (Extended Data Fig. 2a-d). Quantification of OP-puro 
incorporation confirmed that protein synthesis was highest in differentiated populations 
in late anagen (Fig. 2d). Translation in bulge stem cells significantly increased from 
telogen to anagen (Fig. 2d), suggesting a correlation between translation rate and stem 
cell activation. 
 
Next, we focused on HFSCs and their progeny and quantified protein translation in 
tdTomato+ cells that were sorted into bulge stem cells, non-bulge cells, and 
differentiating cells (Fig. 2e,f). Translation rates significantly increased in bulge HFSCs 
from telogen to anagen (Fig. 2e,f). In addition, the average translation rate increased in 
differentiating cells in late anagen, and was around 2-fold higher compared to the 
background cells (tdTomato-) (Fig. 2d-f; Extended Data Fig. 2e,f). These results were 
robust to the specific threshold used to identify cells as highly translating (top 2.5% - 
50%) (Extended Data Fig. 3a-c). 
 
Thus, as stem cells proceed into a fully committed progenitor state, protein translation 
steadily increases. 
 
Proliferation does not determine protein synthesis 
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Protein synthesis was highest in growing hair follicles. However, cellular division alone 
did not explain translation rates as the greatest protein synthesis was found in 
differentiating but non-dividing (Ki67-negative) cells (Fig. 2g). Although the 
percentage of cycling (S/G2/M) cells correlated with increasing translation rates 
(Extended Data Fig. 3d,e), differentiating (CD34-/6-) and non-dividing (G1/G0) cells 
represented the population with the highest translation (Extended Data Fig. 3f,g).  
 
To directly test whether protein synthesis was determined by lineage commitment 
instead, we measured the translation rate in bulge HFSC and their offspring 
(tdTomato+) along the cell cycle. In late anagen, non-cycling (G1/G0) stem and 
progenitor cells synthesized significant more protein than their cycling (S/G2/M) 
counterparts (Fig. 2h; Extended Data Fig. 3h). Thus, increasing translation rates 
correlated with stem cell commitment and differentiation rather than proliferation 
(Extended Data Fig. 4p).  
 
Dividing tumour-initiating cells synthesize low levels of protein 
To test whether low protein synthesis simply reflected a quiescent state, we investigated 
translation rates in cancer-initiating cells, which exhibit both high self-renewal and 
proliferation capacity. We used K5-SOS mice, which constitutively activate RAS in 
basal epidermal cells and develop well-differentiated tumours resembling human 
squamous tumours23,24.  
 
Undifferentiated progenitors (UP) expressed markers for tumourigenesis and tumour-
initiating cells (Itg1, Itg6, CD44, CD34, PDNP)25-29, and exhibited lower protein 
synthesis than committed progenitors (CP) (Fig. 3a,d; Extended Data Fig. 4a-c,f-j). 
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Translation was highest in supra-basal and differentiating CP (K10+), but absent in 
terminally differentiated (TD), non-tumourigenic cells (Fig. 3a,b). In cancer, elevated 
translation has been associated with increased proliferation30. However, in our data high 
translation was uncoupled from proliferation because both OP-puro-high and -low cells 
expressed Ki67 (Fig 3c), and protein synthesis did not correlate with cycling cells (Fig. 
3e). 
 
Thus, similar to normal skin, stem and progenitor cells in tumours produced less protein 
than their committed progeny.   
 
Forced reduction of protein synthesis enriches for tumour-initiating cells 
To test whether low translation is cause or consequence of a stem cell state requires the 
ability to modulate protein synthesis. An excellent system is the genetic deletion of the 
RNA-methyltransferase NSun2. NSun2 modulates global translation by protecting 
tRNAs from cleavage1. In normal skin, NSun2 is restricted to distinct hair follicle 
populations11 that overlap with OP-purohigh cells in early and late anagen (Extended 
Data Fig. 4k,l). NSun2-deletion delayed HFSC differentiation in adult11 and developing 
skin (Extended Data Fig. 4m-o). NSun2 is up-regulated in epithelial tumours and 
homogenously expressed in mouse and human squamous cell carcinomas (Extended 
Data Fig. 5a)31,32, and its expression is restricted to highly translating cells in K5-SOS 
tumours (Fig. 3f).  
 
We deleted NSun2 in K5-SOS mice, and measured OP-puro incorporation into the 
offsprings’ tumours. As expected, NSun2-ablation reduced protein synthesis in tumours 
(Fig. 3g-i; Extended Data Fig. 4d,e). K5-SOS/NSun2-/- mice developed more tumours 
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that appeared earlier, grew larger, and reduced the life span (Fig. 4a; Extended Data 
Fig. 5b-d).  
 
NSun2-/- tumours appeared more proliferative; however, EdU/BrdU pulse-chase 
experiments revealed that high EdU incorporation reflected an increased 
undifferentiated population, but not a faster division rate (Fig 4b,c; Extended Data Fig. 
5e,f). NSun2-/- tumours were poorly differentiated and in a later stage of 
tumourigenesis as shown by increased expression of stem cell- and tumour progression-
markers (Fig. 4d-i; Extended Data Fig. 5f-j).  
 
To test for the cell-intrinsic, tumour-initiating potential, we injected NSun2-/- tumour 
cells subcutaneously into nude mice (Extended Data Fig. 6a). Only NSun2-/- cancer 
cells reconstituted the original squamous tumour with high proliferative potential and 
elevated levels of Itg1 and PDPN (Extended Data Fig. 6b-f). Thus, NSun2-deletion 
enhances self-renewal potential of tumour-initiating cells in a cell-autonomous manner. 
 
Also in human skin cancer NSun2 expression was inversely correlated with 
malignancy, when we compared protein expression levels in normal skin and cutaneous 
cancers of increasing TNM stages (Fig. 4j; Extended Data Fig. 6g-m).  
 
These results argue that reduction of translation rates caused by NSun2-deletion 
increased the tumour-initiating population. 
 
tRNA fragments as mediators of a stem cell translational programme 
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A likely mechanism for translational repression in NSun2-deficient tumours was that 5’ 
tRNA fragments inhibit protein synthesis4. Using RNA bisulphite-sequencing1,33, we 
confirmed that in tumours, NSun2-dependent methylation occurred at most tRNAs 
(65%), but only at a small proportion of mRNA exons (2%) and introns (Fig. 5a,b; 
Extended Data Fig. 7a-e; Supplementary Table 1,2)1,2,34-39. In the few mRNAs, NSun2-
methylation sites were enriched close to transcriptional start sites, but uncorrelated with 
RNA abundances (Extended Data Fig. 7f,g; Supplementary Table 1,3). In contrast, 
hypo-methylation of tRNAs directly caused by loss of NSun2 lead to the accumulation 
of 5’ tRNA fragments (Fig. 5c,d; Extended Data Fig. 7i-l; Supplementary Table 2,4).  
 
We performed ribosome profiling to evaluate how 5’ tRNA fragments influenced 
translation in mouse tumours and patient-derived NSun2-deficient fibroblasts 
(Extended Data Fig. 8a,b; Supplementary Tables 5,6a-c). We verified the high quality 
of our data by testing for triplet periodicity of ribosomal footprints40, increased 
ribosomal density near translation start sites41, and correlation between RNA 
expression levels and translation (Extended Data Fig. 8c-j)42.  
 
The distinct translational programme in NSun2-/- tumours was not driven by 
transcription, because the changes in protein synthesis caused by NSun2-removal were 
decoupled from the corresponding changes in RNA expression levels (Fig. 5e; 
Extended Data Fig. 8e). These differences in translation were more likely to be caused 
by accumulated 5’ tRNA fragments than by changes in mRNA methylation, because 
translation of NSun2-methylated mRNAs remained unaltered (Extended Data Fig. 7h).  
 
 11 
In sum, the undifferentiated cellular phenotype of NSun2-/- tumours was primarily 
driven by translational, and not transcriptional changes. 
 
Changes in tRNA methylation impose a distinct translational signature  
Accumulation of 5’ tRNA fragments can activate a cap-independent stress-response 
programme4; and stress stimuli can increase ribosomal density in 5’ untranslated 
regions (UTR)43,44. Consistent with such a stress response, 5’UTRs in NSun2-deficient 
cells showed increased ribosome densities (Fig. 5f,g; Extended Data Fig. 8k,l; 
Supplementary Table 7-9). The increased ribosome density in 5’UTRs is likely due to 
the occurrence of up-stream open reading frames (uORFs)41,45. Functionally, uORFs 
repress translation by sequestering initiation events or facilitate downstream re-
initiation and translation45-48, which may explain why protein synthesis of 
corresponding coding sequences (CDS) remained unaltered (Fig. 5f,g). 
 
Although the underlying mechanisms are unclear, differential ribosome density in 
5’UTRs should alter protein production of distinct genes. Indeed, transcripts with 
increased ribosome density in 5’UTRs were linked to apoptosis, stress response, cell 
shape and migration (Fig. 5h-j). In tumours, transcripts with reduced ribosome density 
in the CDS were related to differentiation (Fig. 5h,i). Thus, the ribosome profiling data 
correlated well with the phenotypic reduction of epidermal differentiation of NSun2-
deficient tumours; and the cell-intrinsic NSun2-controlled translational programme(s) 
related to stress responses and cell motility was conserved between species.  
 
To identify the translational programme that directly depended on RNA methylation, 
we performed ribosomal profiling after rescuing NSun2-/- human fibroblasts with the 
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wild-type or enzymatically dead constructs of NSun2 (Extended Data Fig. 9a-d). 
Modulators of cell adhesion and motility represented a quarter of translational repressed 
transcripts that depended on the enzymatic activity of NSun2 (Extended Data Fig. 9e-
g; Supplementary Tables 10a-c). Consequently, motility and adhesion were down-
regulated but differentiation up-regulated in primary human keratinocytes when NSun2 
was repressed or enzymatic-dead versions over-expressed (Extended Data Fig. 9h-m).  
 
Thus, the undifferentiated stem cell state in NSun2-deficient tumours was primarily 
driven by differential translation of proteins regulating cell migration, adhesion and 
stress responses (Extended Data Fig. 10a,b; Supplementary Fig. 1). 
 
Low translating tumour-initiating cells are highly sensitive to anti-cancer drugs 
To test whether the stress-related programme in NSun2-/- tumours altered their 
sensitivity to external stress in vivo, we applied the cytotoxic agent 5-fluorouracil 
(5FU). 5FU is commonly used to treat squamous cell carcinomas49. While wild-type 
tumours only showed a mild reduction in growth, 5FU-treatment blocked progression 
of NSun2-/- tumours (Fig. 6a; Extended Data Fig. 10c,d). NSun2-/- tumour cells were 
unable to re-enter the cell cycle after drug treatment, despite induction of p53 being 
detectable in all samples (Fig. 6b,c; Extended Data Fig. 10e,f). We obtained similar 
results using cisplatin (Extended Data Fig. 10g-i). 5FU-treated NSun2-/- tumour cell 
layers were reduced, and the remaining basal cells (Itg6) unusually labeled double-
positive for the differentiation marker K10 (Fig. 6d; arrows). Thus, NSun2-deficient 
tumours fail to activate survival pathways in response to stress. 
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Finally, we asked whether the increased sensitivity to 5FU depended on angiogenin-
mediated cleavage of non-methylated tRNAs. We rescued tRNA cleavage by 
administering the angiogenin-inhibitor N65828 (AI)1,50. High toxicity of this drug 
combination only allowed treatment times up to 7 days. Nevertheless, NSun2-/- 
tumours failed to regress and survival of undifferentiated tumour-initiating cells 
(CD34+/6H) significantly increased when exposed to both drugs (Fig. 6e,f), indicating 
that tRNA fragments reduce the survival of NSun2-/- tumour-initiating cells.  
 
Thus, combining cytosine-5 RNA methylation inhibitors with conventional 
chemotherapeutic agents may provide an effective anti-cancer strategy for solid 
tumours (Extended Data Fig. 10j).  
 
 
Discussion 
Similar to the haematopoietic system19, epidermal stem cells produce less protein than 
their immediate progenitors, and forced entry into the cell cycle is not sufficient to 
reverse this translation repression. Instead, global protein synthesis in normal and 
tumour cells is determined by lineage commitment, but not by proliferation.  
 
Here, we identify RNA methylation as an important pathway to modulate global protein 
synthesis and cell fate. Both protein synthesis and NSun2 expression are low in 
epidermal stem cells, but increase upon commitment to differentiate. NSun2-mediated 
methylation protects tRNA from cleavage into non-coding 5’ tRNA fragments, thereby 
promoting protein translation and differentiation1. External stress stimuli inhibit NSun2 
activity1 permitting cleavage into 5’ tRNA fragments, which then decrease protein 
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synthesis in human cells4. Inhibition of post-transcriptional methylation in squamous 
tumours promotes stem cell function and tumourigenesis. However, re-activation of 
cytosine-5 RNA methylation pathways is required to exit the specific translation 
inhibition programme after cytotoxic stress. Thus, activation of RNA methylation or 
inhibition of tRNA cleavage is essential for cell survival of tumour-initiating cells in 
response to cytotoxic stress (see Supplementary Discussion).  
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Material and Methods are submitted as supplementary file.  
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Figure legends 
Figure 1. Hair follicle stem cells synthesize less protein than their progeny. a, 
Epidermal populations analyzed. IFE: interfollicular epidermis, SG: sebaceous gland, 
BG: bulge, HG: hair germ, DP: dermal papilla. b, Treatment regimes. c-f, Detection of 
tdTomato (tdTom) and OP-puro in back skin of tdTom mice in telogen (c,d) and late 
anagen (e,f). Arrows: tdTom+ cells (magnification lower panels). Arrowheads: 
tdTom+/OP-purohigh cells. Dotted line: lower bulge. g-j, OP-puro and hair follicle 
lineage markers (late anagen). Dotted lines: cross section (i, ii). k, Schematic summary 
of (g-j). OP-puro+ layers (green). Scale bars: 50 m. 
 
Figure 2. Protein synthesis correlates with differentiation. a-c, Experimental set up. 
d-f, Violin plots of normalized protein synthesis in OP-purohigh cells sorted for indicated 
epidermal populations (c). Itg6: 6. g, Ki67 and OP-puro detection (late anagen). 
Arrowheads: Ki67-/OP-puro+ cells. Scale bar: 50 m. h, Box plots of protein synthesis 
in cycling (S/G2/M) and non-dividing (G1/G0) OP-purohigh cells. n=mice. *p<0.05, 
**p < 0.01, ***p < 0.001, ****p<0.0001 (Two-tailed Student’s t-test). Source data: 
SI_Fig2. 
 
Figure 3. Tumour-initiating cells synthesize less protein than their progeny. a-c, 
Co-labeling OP-puro with indicated markers. Arrows: marker+ cells. d, Flow cytometry 
for OP-puro incorporation. e, Percentage of dividing cells (S/G2/M) and normalized 
protein synthesis (mean± s.d.; n=mice). f, Co-staining OP-puro, NSun2, Itg6. Arrows: 
OP-puro+/NSun2+ cells. g-i, OP-puro-detection in sections (g, h) or by flow cytometry 
(i). Arrowheads: OP-purolow cells. Nuclei: DAPI. Scale bars: 50 m. Dotted line: basal 
membrane. All analyses are in K5-SOS tumours. Source data: SI_Fig3. 
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Figure 4. NSun2-deletion promotes stem cell identity and tumourigenesis. a, 
Tumour incidence. †: Deceased. b, c, Detection (b) and quantification (c) of pulsed-
chased BrdU+ and EdU+ cells in tumours (see Methods). n = 5 slides x 3 mice. d, e, 
Immunostaining for Itg6, K10 (d) and PDPN (e). Arrows: marker+ cells. Nuclei 
(DAPI); dotted line: basal membrane; scale bars: 100 μm. f-i, Flow cytometry (f, g) and 
quantification (h, i) of marker+ tumour cells. n=mice. j, NSun2 protein expression in 
human normal skin or tumours (mean ± s.d.). *p < 0.05; ***p< 0.001 (two-tailed 
Student’s t-test). Source data: SI_Fig4. 
 
Figure 5. NSun2-deletion imposes distinct translational programmes. a, b, 
Percentage of NSun2-methylated cytosines (dark red). c, Un-methylated tRNAs are 
cleaved and 5’tRNA fragments accumulate. d, Relative frequencies of tRNA fragments 
in tumours. e, No correlation between changes in protein synthesis and RNA expression 
in tumours. f, g, Significantly (p<0.05) changed 5’UTR ribosome densities in tumours 
(f) and human NSun2-/- lines (excluding significant (p<0.05) changes in NSun2+/-) (g) 
and corresponding CDS. ****p<0.0001 (two-tailed Student’s t-test). h, i, Frequency of 
ribosomal density values (p-value<0.05 and abs(log2FC)>0) (h) and Gene Ontology 
(GO) categories in tumours. j, GO categories of significant (p<0.05) changed 5’UTRs 
in NSun2-/- lines versus +/-. Data: average of 4 replicates per condition in human (g, j) 
and mouse (a-d) or 3 in (e,f,h,i).  
 
Figure 6. NSun2-deletion sensitizes tumour-initiating cells to cytotoxic stress. a-c, 
Tumour size (mean ± s.e.m) (a) and Ki67 detection (b, c) in control (Ctr) or 5’FU-
treated mice. d, K10 and Itg6 detection in treated NSun2-/- tumours. Arrows: 
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K10+/Itg6+-positive cells. e, Tumour size in mice treated with 5’FU and/or angiogenin 
inhibitor (AI). f, Quantification of tumour-initiating cells in tumours shown in (e) 
(mean ± s.d.). *p < 0.05; **p< 0.01 (two-tailed Student’s t-test). n=mice. Scale bars: 
100 m. Source data: SI_Fig6. 
 
Extended Data Figure legends 
Extended data figure 1. Protein synthesis in epidermal populations. a, Hair cycle 
stages and genetic lineage marking using K19- and Lgr5 tdTomato (tdTom) mice. Cell 
surface markers to isolated bulge stem cells are CD34 and Itg6. Telogen: stem cells 
(CD34+/Itg6+) are quiescent and resting in the bulge (BG). Early anagen: stem cells 
divide and give rise to committed progenitors in the hair germ (HG), which then grow 
downwards into the bulb (BU) surrounding the dermal papilla (DP). Late anagen: cells 
differentiate upwards to form the hair. Catagen: intermediate phase, when the hair bulb 
degenerates into a new resting bulge. IFE: interfollicular epidermis; SG: sebaceous 
glands. Mouse transgenes label K19 (red)- and Lgr5 (orange)-positive stem cells and 
their progeny. b, OP-puro detection in mouse epidermis at all hair cycle stages. Dotted 
lines: hair follicle and epidermal basal layer. Arrows: OP-purohigh cells in the hair 
follicle. Arrowheads: OP-purolow cells in the interfollicular epidermis. Nuclei (DAPI). 
c, tdTomato and OP-puro detection in back skin of K19tdTom and Lgr5tdTom mice in 
telogen and late anagen. Arrows: Tomato+ cells. Arrowheads: Tomato+/OP-purohigh 
cells. Dotted line: lower bulge. Merged panels in Figure 1c-f. e, Hair follicle lineages 
and differentiation markers used in Figure 1g-j. ORS: outer root sheet; Cp: Companion 
layer; IRS: inner root sheet; He: Henle’s layer; Hu: Huxley layer; Ci: cuticle of inner 
root sheet; Ch: cuticle; Co: cortex; Me: Medulla. f, P-cadherin and OP-puro detection 
in a late anagen. Scale bars: 50 m. 
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Extended data figure 2. Quantification of protein synthesis in epidermal 
populations. a, b, Top 2.5%, 10%, 25%, and 50% translating epidermal cells (OP-
purohigh) (a) were sorted for CD34 and Itg6 (b). c, Protein synthesis in CD34+/6+, 
CD34-/6+ and CD34-/6- epidermal populations in the top 2.5%, 10%, 25%, 50% or 
100% (all) translating cells at indicated hair follicle stages. d, Percentage of 
CD34+/6+, CD34-/6+ and CD34-/6- cells in the top 2.5%, 10%, 25%, 50% or 
100% (all) of translating epidermal cells at indicated stages of the hair cycle. Bars: 
mean ± s.d. e, f, Violin plots of protein synthesis in top 2.5% OP-purohigh cells in 
tdTomato-negative (tdTom-) epidermal cells sorted for CD34 and Itg6 from K19- (e) 
or Lgr5-tdTom mice (f) at all stages of the hair cycle. (n=mice). Source data: SI_EDF2. 
 
Extended data figure 3. Protein synthesis and cell cycle analyses in epidermal cells. 
a-c, Violin plots of protein synthesis in indicated epidermal populations sorted for K19- 
(a) and Lgr5-tdTomato-positive (tdTom+) (b) and –negative (c) populations. Protein 
synthesis is shown for top 10%, 25%, or 50% OP-purohigh cells. d, e, Cell cycle analysis 
(d) and percentage of cells in G1/G0 or S/G2/M in the top 2.5%, 10%, 25% or 50% 
OP-purohigh cells in late anagen (e). Data represent mean ± s.d. f, Scatter plots 
correlating protein synthesis in the 2.5% OP-purohigh population with percentage of 
cells in S/G2/M (upper panel) and G1/G0 (lower panel) using all samples independent 
of hair cycle stage. Linear regression, correlation coefficient (r2) and P-value are shown. 
g, Box plots of protein synthesis (upper panel) and number of cycling cells (lower 
panel) in the top 2.5% translating cell populations (OP-purohigh). h, Box plots of protein 
synthesis in cycling (S/G2/M) and non-dividing (G1/G0) cells in the 2.5% OP-purohigh 
population isolated from Lgr5tdTom mice. Shown are all cells (upper panel), 
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tdTomato-negative (Tom-) (middle panel) and tdTomato-positive (Tom+) (lower 
panel) cells at the indicated hair cycle stages. Two-tailed Student’s t-test. **p < 0.01, 
***p < 0.001, ****p<0.0001. (n=mice). Source data: SI_EDF3. 
 
Extended data figure 4. Protein synthesis in squamous tumours. a-c, Co-labelling 
of OP-puro with markers for undifferentiated basal cells: Itg6 (a), CD44 (b) and 
PDPN (c) in mouse tumours. Nuclei (DAPI). Arrows: low translating marker+ cells. 
Dotted line: invasive front of the tumour. Insets: magnified images (a’-c’’). d, Gating 
of low, medium and high OP-puro cells in Nsun2+/+ (wt) and NSun2-/- K5-SOS skin 
tumours analysed in (e-g). e, Percentage of OP-purolow cells in tumours from Nsun2+/+ 
(wt) and NSun2-/- K5-SOS mice. f, g, Flow cytometry for Itg6 and CD34 in 
unfractionated epithelial cells from mouse tumours (All cells) or epithelial cells with 
high, medium and low OP-puro incorporation (f) and quantification (g) (mean  ±  s.d.; 
n=3 mice). h, Flow cytometry for Itg6 and CD44 in unfractionated epithelial cells 
from mouse tumours. i, j, Histogram (i) showing OP-puro incorporation of cells as 
gated in (h) and quantification (h) (mean  ±  s.d.; n=4 mice). k, l, Endogenous 
expression of NSun2 (LacZ) in early (P23) (k) and late (30) anagen (l) hair follicles. 
Sections were co-stained with eosin or markers for bulge stem cells (K15) and the hair 
lineages Huxley’s (Hu), cuticle (Ci) (GATA3), and cortex (Co) (LEF1). m-o, 
Haematoxylin & Eosin staining (m) and immunostaining for LEF1 (n), K72 and DLX3 
(o) in wild-type (WT) and NSun2-/- skin at P1. Nuclei (DAPI). Insets: magnified boxed 
area (i, ii). Scale bars: 50 μm. (p) Correlation between proliferation and protein 
synthesis with differentiation of quiescent (QSC) or committed stem cells (CSC), 
committed progenitors (CP), differentiating progenitors (DP), and terminally 
differentiated (TD) cells. Source data: SI_EDF4. 
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Extended data figure 5. NSun2 in mouse skin squamous cell carcinomas. a, 
Immunostaining for NSun2, Itg6, K10 (differentiation marker), Laminin 5 and K8 
(tumour progression markers), and Slug (epithelial to mesenchymal transition-related 
gene) at different stages of DMBA-TPA-induced malignant progression to squamous 
cell carcinoma (SCC). b-d, Quantification of tumour diameter normalized to body 
weight (BW) (b), tumours per mouse (c), and mouse life span (d) in K5-
SOS/NSun2+/+ (K5-SOS), K5-SOS/NSun2+/- and K5-SOS/NSun2-/- littermates. 
Measurements start at P16. Data collection discontinued when mice deceased (†). Data 
represent mean, n ≥ 5 mice of each genotype. e, f, Haematoxylin & Eosin staining (e) 
and immunostaining for Itg1 (f) in sections from K5-SOS (K5-SOS/NSun2+/+) and 
K5-SOS/NSun2-/- skin tumours. b: Basal undifferentiated cells; sb: suprabasal layers. 
Arrows: Itg1+ cells. g, Relative mRNA expression levels of the indicated transcripts 
in skin tumours (mean ± s.d.; n=mice). h, Flow cytometry using Itg6 and CD44 in 
K5-SOS/NSun2-/- and control K5-SOS (K5-SOS/NSun2+/+) tumours. i, Percentage of 
cells in cell populations as gated in (h) (mean  ±  s.d.; n=mice). *p < 0.05; ***p < 0.001 
(two-tailed Student’s t-test) (i). j, TUNEL assay on sections of K5-SOS tumours 
expressing (K5-SOS NSun2+/+) or lacking NSun2 (K5-SOS NSun2-/-). Arrows: 
TUNEL+ (apoptotic) cells. Nuclei (DAPI) and dotted line: boundary of epithelia and 
stroma (f, j). Scale bars: 25 μm (a), 100 μm (e,f,j). Source data: SI_EDF5. 
 
Extended data figure 6. Deletion of NSun2 enhances self-renewal of tumour-
initiating cells in a cell-autonomous manner and NSun2 expression in human skin 
tumours. a, Tumour size after grafting of K5-SOS/NSun2+/+ (K5-SOS) and K5-
SOS/NSun2-/- tumour cells subcutaneously into nude mice (mean  ±  s.d.; n = 3 mice). 
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b-f, Histology (H&E staining) (b), staining for GFP (c), Ki67 (d)  Itg1 (e), and 
PDPN (f) in grafted tumour sections. Dotted line: boundary between epithelia and 
stroma. Arrows: basal and suprabasal expression. Nuclei (DAPI). g-l, 
Immunohistochemistry for NSun2 in human normal skin, benign tumours, malignant 
basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) with increased 
malignancy (stages classified using the TNM (Tumour, Node, Metastases) system). 
Arrows: NSun2high cells. Arrowheads: NSun2low cells. (m) Distribution of cells shown 
in (g-l) according to NSun2 protein levels. (n ≥ 3 samples). Scale bars: 100 m. Source 
data: SI_EDF6. 
 
Extended data figure 7. NSun2-dependent RNA methylation of coding and non-
coding RNA in tumours. a, Percentage of NSun2-methylated sites (>0.15 m5C in 
NSun2+/+; <0.05 m5C in NSun2-/-) out of all covered sites (left hand panel) and in 
non-coding RNA (ncRNA) or introns and exons (right hand panel). b, Methylation level 
in coding and non-coding RNAs (>0.15 m5C in NSun2+/+; <0.05 m5C in NSun2-/-; 
coverage >10 reads). c-e, Examples of NSun2-targeted non-coding RNA (Rpph1) and 
mRNA (Elf1 and Dscaml1) in NSun2+/+ (upper panels) and NSun2-/- (lower panels) 
tumours. f, Number of NSun2-methylated sites in exons 1 to 60 (upper panel) or 
distance from the transcriptional start site (TSS) in introns (lower panel). Plotted sites: 
>0.1 m5C in NSun2+/+; <0.05 m5C in NSun2-/-; coverage >10 reads. g, No correlation 
between NSun2-methylation shown in (b) and RNA abundance in normal skin or K5-
SOS skin tumours. NSun2 is highlighted as a control. h, Venn diagram with no 
significant overlap between NSun2- methylation targets shown in (b) and differentially 
translated mRNAs (p<0.05; measured as ribosome density of NSun2+/+ versus NSun2-
/- tumours). i-l, NSun2-methylation in tRNAs (>0.15 m5C in NSun2+/+; <0.05 m5C in 
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NSun2-/-; coverage >10 reads) (i). Number and location of lost (red) or unchanged 
(grey) m5C sites in NSun2-/- K5-SOS tumours. X-axis: nucleotide position in tRNA (j). 
Examples of NSun2-targeted tRNAs in NSun2+/+ (upper panels) and NSun2-/- (lower 
panels) K5-SOS tumours (k,l). Heat maps show methylated (red) and un-methylated 
(grey) cytosines. X-axis: cytosines. Y-axis: sequence reads. Numbers indicate the m5C 
position in the RNA (c-e;k,l). Bisulphite-seq and RNA-seq data represent average of 4 
replicates per condition. 
 
Extended Data Figure 8. NSun2-deletion drives translational changes independent 
of mRNA expression. a, Ribosome profiling and RNA sequencing experiments (see 
Figure 5) using NSun2-expressing (NSun2+/+) and NSun2-deficient (NSun2-/-) K5-
SOS skin tumours, or cultured human skin fibroblasts (NSun2-/-Line1 and Line2 and healthy 
donors: NSun2+/-, NSun2+/+). HTS (High Throughput Sequencing). b, Correlation 
between protein synthesis (ribosome footprint density) in NSun2+/+ and -/- tumours. 
c, Example of triplet periodicity in ribosome footprints (K5-SOS/NSun2+/+, replicate 
1) shown as number of reads against nucleotide position relative to the translation start 
site for all open reading frames. d, Heat maps showing ribosome footprint reads around 
the translational start site (0) in NSun2+/+ and NSun2-/- tumours (3 replicates per 
condition; ribosome density > 0; colour: RPKM values of footprints). e, Log2 fold-
change (FC) per transcript in normal skin (left hand panel) and tumour samples (right 
hand panel) of significant (p<0.05) expression differences. NSun2 RNA levels (red). f-
j, Scatter plots, linear regression lines and coefficient of correlation (r2) of mRNA 
expression and protein synthesis (density of ribosome footprints per kb) in NSun2+/+ 
(grey) and -/- (red) mouse tumours (f) and human fibroblasts (g-j). k, Venn diagram of 
transcripts with significant (p<0.05) different ribosome footprint density in the 5’UTR 
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in NSun2+/-, NSun2-/-line1 and NSun2-/-line2 human fibroblasts relative to NSun2+/+ 
cells. l, Box plots of ribosome footprint read counts in the 5’UTR (left hand panel) and 
corresponding CDS (right hand panel) of the 192 transcripts in (k). ****p<0.0001 (two-
tailed Student’s t-test).  
 
Extended data figure 9. RNA methylation-dependent changes of protein synthesis. 
a, Venn diagram of transcripts with differential protein synthesis in NSun2+/- and 
NSun2-/- human fibroblasts relative to NSun2+/+ cells. b, GO terms enriched in 424 
commonly differentially translated transcripts in NSun2-/- lines (a). c, Western blot for 
NSun2 and tubulin in NSun2-/- human fibroblasts rescued with viral constructs 
expressing wild-type NSun2 (NSun2-wt), two catalytically dead mutants (C271A and 
C321A) or the empty vector. d, Venn diagram of differentially translated genes in the 
indicated rescued cells relative to empty vector-infected control cells. Translation of 
173 out of 746 of transcripts (23%) depended on the enzymatic activity of NSun2. e-g, 
Differential translation of transcripts relative to NSun2-/- cells (infected with empty 
vector) showing reduced translation in the presence of wild-type (wt) NSun2 but not 
the enzymatic-dead versions of NSun2 (C271A, C321A), corresponding GO categories 
(f) and examples (g). h, Boyden chamber migration assay towards epidermal growth 
factor (EGF) or control medium (ctr) using primary human keratinocytes transduced 
with a siRNA for NSun2 (si_NSun2) or a scrambled construct (si_ctr). Data represent 
mean ± s.d. (n=3 assays). Western blot confirms down-regulation of NSun2 in the 
presence of the siRNA construct. i, j Reduced motility in keratinocytes expressing the 
enzymatic-dead NSun2 construct (K190M) (K190M: n=13; NSun2: n=19 cells) (i). 
Western Blot confirms equal protein expression levels of K190M and NSun2 (j). k, 
Reduced differentiation in primary human keratinocytes expressing the enzymatic-dead 
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NSun2 (K190M). Staining for NSun2, Itg6 or Involucrin (IVL) and nuclei (DAPI). 
Control: empty vector (left hand panels); NSun2: wild-type NSun2 (middle panels), 
K190: enzymatic-dead NSun2 (right hand panels). Arrows: NSun2-expressing Itg6-
/IVL+ cells. Arrowheads: K190M-expressing Itg6+/IVL- cells. l, Flow cytometry for 
Itg6 of keratinocytes transduced with NSun2 (blue line, upper panel), K190M (blue 
line, lower panel) or the empty vector (eVector) (red line). Negative control (grey line) 
represents unstained cells. m, Quantification of IVL+ infected keratinocytes grown in 
suspension for 24 hours to stimulate differentiation. *p<0.05; **p<0.01 (two-tailed 
Student’s t-test) (h-m). Scale bar: 100 μm. Source data: SI_EDF9. 
 
Extended data figure 10. Protein expression differences, drug treatment of NSun2-
/- tumours and graphical summary. a, b, Western blot analysis of translationally 
repressed (a) or induced (b) mRNAs in NSun2-/- (-/-) compared to NSun2+/+ (wt) skin 
tumours with quantification of band densitometry on the right (mean  ±  s.d.; n =3 mice). 
*p < 0.05; ***p<0.001 (two-tailed Student’s t-test). c, d, Control and 5’FU-treated 
tumours, before and after treatment. e, f, Immunohistochemistry for p53 in tumours 
shown in (c,d). g-i, Immunostaining for cleaved caspase 3 (Cl-Casp3) (g), Ki67 (h), 
Itg6 and K10 (i) in K5-SOS tumours expressing (+/+) or lacking (-/-) NSun2 and 
treated with CDDP (see Methods). Scale bars: 100 m. j, Graphical summary: 1. 
Quiescent undifferentiated stem and progenitor cells are characterised by the absence 
of NSun2 and low global protein synthesis. 2. Up-regulation of NSun2 counteracts 
angiogenin-mediated cleavage of tRNAs through site-specific methylation of tRNAs 
allowing increased translation of lineage-specific transcripts driving terminal 
differentiation. 3. Cytotoxic stress inhibits NSun2 and global protein synthesis in 
particular of lineage-specific transcripts and promotes an undifferentiated quiescent cell 
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state. Yet cell survival after the insult requires re-methylation of tRNAs by NSun2 (see 
2.). 4. The inability to up-regulate NSun2 in response to the cytotoxic insult leads to 
cell death. Source data: SI_EDF10. 
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Methods 
Transgenic mice  
Rosa-CAG-LSL-tdTomato51, K19-CreER52 and Lgr5-CreERT253, NSun2-/- (or 
homozygous NSun2Gt(D014D11)Wrst)54, and K5-SOS-F (in wa2/wa2 background)55 mutant 
mice have been described previously. Balb/C athymic nude mice purchased from 
Charles River were used in transplantation experiments. All mice were housed in the 
Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute Animal 
Unit. All mouse husbandry and experiments were carried out according to the local 
ethics committee under the terms of a UK Home Office license PPL80/2231 and 
PPL80/2619. 
 
To conditionally induce tdTomato-reporter lines for expression of Cre-recombinase, 
Rosa-CAG-LSL-tdTomato mice were crossed with K19-CreER or Lgr5-CreERT2 
mice. To activate CreER, only male mice were treated with two intra-peritoneal (IP) 
injections of 50 l of a Tamoxifen (Sigma-Aldrich) solution (40mg/ml) in corn oil at 
post-natal day 15 and 17.  
 
To measure protein synthesis in vivo, mice were intraperitoneally injected with O-
Propargyl-puromycin (Op-puro) (Medchem Source LLP) at a concentration of 50 mg 
per kg of body weight dissolved in PBS at pH 6.4–6.6 one hour before sacrifice. Skin 
samples were collected at Catagen (postnatal day P17), telogen (P19), early anagen 
(P25) and late anagen (P30). 
 
To induce squamous tumours in NSun2-/- background, we used K5-SOS transgenic 
mice. These mice express a dominant negative form of Son of Sevenless (SOS) under 
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control of the keratin-5 (K5) promoter and develop spontaneous cutaneous tumour with 
100% penetrance55. K5-SOS-Fxwa2/wa2 mice were crossed with NSun2+/- mice 
carrying a gene trap in the NSun2 allele (NSun2Gt(D014D11)Wrst). Spontaneous skin 
papillomas developed mainly in the tail of K5-SOS-Fxwa2/+ mice two weeks after 
birth but they did not develop into malignant squamous cell carcinomas55.  
 
Histology, tissue and cell stainings, antibodies and imaging 
Tissues or tumours were either embedded in OCT and frozen or fixed overnight with 
4% paraformaldehyde, transferred to 70% EtOH and embedded in paraffin. Samples 
were then cut at 4 m (paraffin) or 10 m (frozen). Immunofluorescence staining, LacZ 
and Hematoxylin and Eosin staining of frozen or paraffin-embedded tissues or cells 
were performed as described previously54. For immunohistochemistry ImmPRESSTM 
reagents (Vector Labs) or IHC Detection Kit (Ventana Medical Systems) and 
DISCOVERY automated IHC staining system (Ventana Medical Systems) were used. 
 
Primary antibodies were used at the following dilutions: rabbit polyclonal to RFP (for 
tdTomato) (1:1000; Rockland inc., 600-401-379), mouse monoclonal to Dlx3 (1:200, 
Abnova, H00001747-A01), rabbit polyclonal to K6 (1:200, Abcam, ab24646), mouse 
monoclonal to Gata3 (1:50, Santa Cruz Biotech, sc-268), guinea pig polyclonal to K31 
and K72 (1:200, Progen, GP-hHa1 and GP-K6irs2), rabbit polyclonal anti c-maf (1:100, 
Bethyl, A300-613A), mouse monoclonal to Lef1 (1:50, Santa Cruz Biotech, sc-81470), 
goat polyclonal to P-cadherin (1:100, R&D systems, FAB761A), rabbit monoclonal 
antibody to Ki67 (1:200; SP6, Vector Labs, VP-RM04), mouse monoclonal anti-mouse 
Keratin 15 (1:100056), -Catenin (1:200, Santa Cruz Biotech, sc-7199), rat monoclonal 
anti-Itg1 (1:200, clone HM1-1, BioLegend, 102203), rabbit polyclonal anti mouse 
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keratin 10 (1:500; Covance, PRB-159P), rabbit polyclonal anti-NSun2 (1:500; Aviva 
Systems Biology, ARP48811_P050), rabbit polyclonal anti-human NSun2 (MetA, 
1:50057), rat monoclonal anti-Itg6 (1:500; GoH3, eBioscience, 14-0495), rat 
monoclonal anti-CD44 (1:200, IM7, BioLegend, 103004), anti-mouse Podoplanin 
(1:500, clone 8.1.1, eBioscience, 14-5381), rat monoclonal anti-BrdU (1:100; Abcam, 
ab6326), rabbit polyclonal anti-Laminin alpha 5 (1:100, Abcam, ab75344), mouse 
monoclonal anti-cytokeratin 8 (1:100, TROMA-I, DSHB, US), rabbit polyclonal to 
Slug (1:200, Cell Signaling, 9585P), chicken polyclonal anti-GFP (1:200, Abcam, 
ab13970), rabbit polyclonal anti-p53 (1:100, CM5, Novocastra, NCL-p53-CM5p), and 
rabbit anti human Involucrin (SY5 clone, 1:200, Abcam, ab80530). Alexa Fluor 555-, 
Alexa Fluor 647- and Alexa Fluor 488-conjugated secondary antibodies (Life 
Technologies) were added at a dilution of 1:1000 for 1 hour at room temperature. 
Apoptotic cells were visualized staining sections with DeadEnd™ Fluorometric 
TUNEL System (Promega) or immunostained for rabbit polyclonal anti-cleaved 
Caspase3 (1:200, Cell Signaling, 9664). Nuclei were labeled with DAPI (49,6-
diamidino-2-phenylindole) or hematoxylin. Slides were mounted in glycerol 
supplemented with Mowiol ® 4-88 mounting medium (Sigma-Aldrich-Aldrich).  
 
White field images were acquired using an Olympus IX80 microscope and a DP50 
camera. Fluorescence images were acquired either on a Zeiss Axioplan microscope or 
using a confocal microscope (Leica TCS SP5) at 1024×1024 dpi resolution. All the 
images were further processed with Photoshop CS5 (Adobe) software. 
 
Isolation of mouse keratinocytes from normal skin and skin tumours  
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To isolate keratinocytes from mouse back skin, shaved skin was floated on 0.25% 
Trypsin without EDTA (Life Technologies) for 2 hours at 37°C. Then the epidermis 
was scraped off the dermis, and cells were disaggregated by gentle mincing with a 
scalpel and pipetting. For back skin in late anagen the dermis was further minced and 
digested for 30 minutes at 37°C low-calcium medium containing 1.25 mg/ml of 
Collagenase Type I, 0.5 mg/ml of Collagenase Type II, 0.5 mg/ml of Collagenase Type 
IV (all from Worthington) and 0.1 mg/ml of Hyaluronidase (Sigma-Aldrich).  
 
To disaggregate cells from squamous tumours, the tumours were minced with a scalpel 
and incubated for 1-2 hours at 37oC in low-calcium medium containing 1.25 mg/ml of 
Collagenase Type I, 0.5 mg/ml of Collagenase Type II, 0.5 mg/ml of Collagenase Type 
IV (all from Worthington) and 0.1 mg/ml of Hyaluronidase (Sigma-Aldrich). Then 
pieces were further incubated for another hour with Trypsin without EDTA (Life 
Technologies) and cells disaggregated by scraping with a scalpel blade. Trypsin was 
inactivated by washing the cell suspension with low-calcium media containing 10% of 
FBS (Life Technologies).  
 
In vivo measurement of protein synthesis by flow cytometry and microscopy 
Back skin or cutaneous tumours were collected and further processed for flow 
cytometry or histology analysis (described above). For flow cytometry analysis cells 
were dissociated as described above. For staining of dissociated cells or frozen sections, 
samples were first fixed with 1% paraformaldehyde in PBS for 15 min on ice. Next 
samples were washed in PBS, and then permeabilized in PBS supplemented with 3% 
fetal bovine serum (Sigma-Aldrich) and 0.1% saponin (Sigma-Aldrich) for 5 min at 
room temperature. To conjugate OP-puro to a fluorochrome, an azide-alkyne 
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cycloaddition was performed using the Click-iT Cell Reaction Buffer Kit (Life 
Technologies) and 5 M of Alexa Fluor 488 or Alexa Fluor 647 conjugated to azide 
(Life Technologies). After the 30-min reaction, the cells were washed twice in PBS 
with 3% fetal bovine serum and 0.1% saponin and then resuspended in PBS. When 
indicated cells were further stained for cell surface markers and DAPI as described in 
a section below.  
 
To visualize protein synthesis together with antibody staining in skin or tumour paraffin 
embedded or frozen sections; frozen sections were first fixed with 1% 
paraformaldehyde in PBS for 15 and paraffin sections were first de-waxed and 
progressive rehydration sections were then blocked and stained with primary antibodies 
overnight at 4C. The next day sections were washed and stained with secondary 
antibodies 1 hour at room temperature. After washes sections were stained using the 
Click-iT Cell Reaction Buffer Kit with Alexa Fluor-647 or 488 azide (Life 
technologies) as described above. 
 
Quantification of protein synthesis rates 
Protein synthesis rates in specific cell populations were calculated by normalizing the 
mean of OP-puro signal of each population of interest to the signal of the whole 
epidermal or tumour cell preparation, using the following formula: 
   (mean OP-puro) population of interest  
   (mean OP-puro) all epidermal or tumour cells (CD117-ve; CD31-ve; CD45-ve) 
The mean of OP-puro incorporation was averaged from several mice collected in 
multiple independent experiments. OP-puro fluorescence signal between experiments 
was calibrated by including in each run BD rainbow Calibration particles 8 peaks (BD 
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Bioscience). Samples from PBS-injected mice were also stained for OP-puro and the 
fluorescence signal was used to determine the background signal.  
 
Flow cytometry and cell cycle analysis 
Flow cytometry was performed for cells dissociated from normal skin, skin tumours or 
cells growing in culture. Cell dissociation from skin or tumours was performed as 
described earlier. Cells in culture were trypsinized for 5 minutes before performing the 
staining. Analysis of specific epidermal or tumour populations, live cells, or fixed cells 
previously stained for OP-puro as indicated in a previous section, were incubated in 2% 
of BSA with combinations of antibodies to the following cell-surface markers: PE-Cy7-
conjugated CD117 (1:100, clone 2B8, BD Bioscience, 558163), PE-Cy7-conjugated 
CD31 (1:50, PE-CAM1, eBioscience, 563651), PE-Cy7-conjugated CD45 (1:100, BD 
Pharmingen, 552848), PE- or eFluor 450- conjugated Itg6 (1:500, clone GoH3, 
eBioscience, 12-0495 and 48-0495), eFluor 660- or FITC-conjugated CD34 (1:50, 
RAM34, eBioscience, 50-0341 and 11-0341), biotinylated CD44 (clone IM7, 
BioLegend, 103004) and PE-conjugated Pdpn (eBioscience, 12-5381-82). After 
incubation for 30 minutes at 4°C, cells were washed twice in PBS. Biotinylated 
antibodies were visualized by incubation with Alexa Fluor 488 conjugated streptavidin 
(Life Technologies) for 10 minutes. For cell cycle analysis cells were further stained 
with DAPI. tdTomato+ cells were detected using PE-Texas Red channel. 
 
Cells were gated using forward versus side scatter to eliminate debris and aggregates. 
Surface markers CD117, CD31 and CD45 were used to gate out endothelial cells, 
melanocytes and blood cells when analyzing cell preparations from skin or tumours. 
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Data acquisition was performed on a BD LSRFortessaTM analyzer (BD Biosciences). 
Data were analyzed by FlowJo software. 
 
Measurement of tumour growth and tumour treatments 
Both male and female mice were used in these experiments. To evaluate the effect of 
NSun2 deletion on the formation of skin tumours we measured the presence (number 
of tumours), the growth of the tumours, the percentage of mice with tumours as well 
the survival of the mice throughout the length of the experiment (approximately 6-8 
weeks). To monitor tumour occurrence and growth mice were weighed, the number of 
all tumours formed all over the body were counted and the growth of each tumour 
monitored every other day from postnatal day 16 (earliest time at which K5-SOS-F 
mice start developing papillomas). Papillomas in the tail tended to fuse into one 
covering the whole tail, and therefore were counted as one tumor from the beginning 
of the experiments. Other tumors also developed in ears, mouth, back skin or feed. The 
growth of each tumour was monitored by measuring the diameter of the widest area of 
the tumour using a precision caliper allowing discriminating size modifications 
>0.1 mm. When animals have to be treated with drugs, experiments started also at the 
third week of age. The end point of the experiments was determined by health 
deterioration and casualties or by the length of the treatments when mice were under a 
treatment regime. K5-SOS-Fxwa2/+NSun2+/+ (referred as K5-SOS/NSun2+/+) 
survived longer than K5-SOS-Fxwa2/+xNSun2-/- (K5-SOS/NSun2-/-) and K5-SOS-
Fxwa2/+xNSun2+/- (K5-SOS/NSun2+/-). All mouse tumour experiments were carried 
out according to the local ethics committee under the terms of a UK Home Office 
license PPL80/2231 and PPL80/2619. Following these regulations the mean diameter 
of a tumour should not normally exceed 1.4 cm (PPL80/2619, 19b 7). While K5-
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SOS/NSun2-/- and K5-SOS/NSun2+/- had to be sacrificed before mice reached two 
moths of age due to the size and aspect of the tumours and weight loss or general health 
deterioration due to excessive tumor burden, K5-SOS/NSun2+/+ only reached the 
deterioration state later than two months of age. For the analysis in Figure 4a we 
measured the percentage of mice with tumours for each indicated day. The average 
number of tumours in each mouse genotype is shown in Extended Data Figure 5c. Note 
that data points are shorter for K5-SOS/NSun2-/- and K5-SOS/NSun2+/- as mice 
survival was shorter. The diameter of the tumours was normalized to the size of each 
mouse (body weight: BW) in Extended Data Figure 5b to eliminate genotype variance 
because K5-SOS/NSun2-/- mice are significantly smaller than K5-SOS/NSun2+/+.  
 
Cutaneous tumours in transgenic K5-SOS/NSun2+/+ and K5-SOS/NSun2-/- mice were 
topically treated with 5-Fluorouracil (5FU) (Efudix 5% Fluorouracil Cream, Meda 
Pharmaceuticals) every second day for two weeks. 5FU inhibits thymidylate synthases 
leading to the up-regulation of p53 and cell death58.  Tumours were also treated with 
5FU in combination with an Angiogenin inhibitor (referred as A.I.) (N65828, NCI, 
US)59,60 administered by intraperitoneal injections at 2 mg/kg in PBS pH 7.4 every 
alternative day to 5FU treatment. Due to the high toxicity of the drug combination, we 
were only able to simultaneously treat with 5FU and AI for a short period of time (up 
to 7 days). Cisplatin (CDDP) (Sigma) was dissolved in PBS and injected 
intraperitoneally at 14 mg/kg every other day. All treatments started the first cutaneous 
lesions appeared and the end point was indicated by the length of the treatment, after 
which all mice were sacrificed. Control mice were administered PBS.  
 
BrdU and EdU labeling 
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To measure proliferation, K5-SOS mice were injected intraperitoneally with 50 mg of 
5-bromo-2′deoxyuridine (BdrU) per kg of body weight, 23 hours later with 20 mg/kg 
of 5-ethynyl-2′deoxyuridine (EdU). One hour later mice were sacrificed and tumor 
samples were processed for histology as described previously. BrdU was visualized as 
described in54. EdU was stained with Click-iT® EdU Alexa Fluor® 488 Imaging Kit 
(Life Technologies). Images of random areas of the slide were collected using a 
confocal microscope (Leica SP5). Numbers of BrdU- and EdU-positive cells were 
quantified using Volocity software (PerkinElmer).  
 
Tumour graft assay 
Epidermal keratinocytes from K5-SOS/NSun2+/+ and K5-SOS/NSun2-/- cutaneous 
tumors were isolated as described in previous sections. GFP expressing dermal 
fibroblasts were isolated from healthy skin of newborn APC-eGFP mice. For this, skin 
was first incubated in a 1:1 solution of 5% dispase (BD Biosciences) at 37ºC for 1 hour. 
The epidermis was then peeled from the dermis. The dermis was incubated with of 
0.2% collagenase in low-calcium medium for 30 minutes at 37°C to yield a single-cell 
suspension. The dermis suspension was filtered through a 70 μm cell strainer. 1x106 of 
viable epidermal keratinocytes from K5-SOS/NSun2+/+ or K5-SOS/NSun2-/- tumours 
were injected subcutaneously in athymic nude mice. To allow successful engrafting, 
the tumour cells were injected with 1x106 of viable GFP dermal fibroblasts. The GFP-
expressing dermal fibroblasts integrated into the dermis but failed to contribute to 
tumour formation (Extended Data Fig. 6c). Experiments were done in triplicates. Nude 
mice were sacrificed one month after transplantation and tumor size was measured with 
a caliper. 
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RNA extraction and quantitative RT-PCR (qPCR) 
Total RNA from mouse skin tumors was prepared using Trizol reagent (Life 
Technologies) and double-stranded cDNA was generated with Superscript III First-
Strand Synthesis kit (Life Technologies). Real-time PCR amplification and analysis 
was conducted in StepOneTM Real-Time PCR Systems (Applied Biosystems) using 
pre-designed probe sets and TaqMan Fast Universal PCR Master Mix (2×) (Applied 
Biosystems). The following probes were used to amplify selected genes NSun2 
(Mm00520224_m1), 6 integrin (Mm01333831_m1), CD34 (Mm00519283_m1), 
Keratin 10 (Mm03009921_m1) and Involucrin (Mm00515219_s1). GAPDH 
expression (4352932E) was used to normalize samples using the ΔCt method. 
 
Mouse SCC and TMA staining and quantification 
Mouse squamous cell carcinomas (SCC) were obtained from a TPA/DMBA chemical 
induction treatment for 20 weeks and frozen tissues were kindly provided by Dr. C. 
Blanpain (Université Libre de Bruxelles, IRIBHM, Brussels B-1070, Belgium.). Frozen 
sections were stained as described in the previous sections.  
 
Tissue microarrays (TMA) for human skin tumours of increased malignancy according 
to TNM (Tumour, Node, Metastases) classification were purchased from Abcam 
(ab178287 and ab178288). Immunohistochemistry was performed using IHC Detection 
Kit (Ventana Medical Systems) and DISCOVERY automated IHC staining system 
(Ventana Medical Systems) with a polyclonal antibody for human NSun2 (MetA, 
1:100057). Images of each tumour section were acquired with a Zeiss Axioplan 
microscope and NSun2 expression levels were quantified for each individual cell in 
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each tissue (quantified as average between all cells in all sections) using CellProfiler 
image software.  
 
Cell culture, viral infections and siRNA knockdown 
Four lines of human dermal fibroblasts were used. Two independent cell lines of 
NSun2-/- human dermal fibroblasts were derived from two patients and referred as 
NSun2-/- line 1 and line 2 in this study, and one line of NSun2+/- fibroblasts was 
derived from the mother of the patients described in61; these three lines were kindly 
provided by Dr. J. Gleeson (Laboratory of Pediatric Brain Diseases, Howard Hughes 
Medical Institute, The Rockefeller University, New York, NY, USA). NSun2+/+ 
human dermal fibroblasts were purchased from Life Technologies (C-013-5C) and 
were derived from an age- and gender-matching individual compared to NSun2+/- 
fibroblasts. Human fibroblasts were grown in MEM (Invitrogen) supplemented with 
20% fetal bovine serum (FBS) as described previously61. ZHC Human epidermal 
keratinocytes (Cellworks distributed, ZHC-1116) were grown in KBM-Gold medium 
(Lonza). All cells were kept in a humidified atmosphere at 37°C and 5% CO2.  
 
To rescue expression of NSun2 or express NSun2 catalytically dead mutants in Nsun2-
/- fibroblasts or ZHC keratinocytes, full length human NSun2 (pB-NSun2), inactive 
mutants C271A (pB-NSun2-C271A), K190M (pB-NSun2-K190M) or C321A (pB-
NSun2-C321A) or the empty vector (pB-empty) were infected via retrovirus as 
described previously62. To knock-down NSun2 expression in human keratinocytes, 
cells were transfected with control siRNA (AllStars negative control siRNA (QIAGEN, 
1027292) or Human NSun2 siRNA (Flexitube siRNA QIAGEN, SI02655548) using 
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Lipofectamine RNAiMax transfection reagent (Life Technologies) according to the 
manufacturer’s instructions.  
 
Migration assays 
For migration analysis in Boyden chambers, human primary keratinocytes were 
transfected with siRNAs as described earlier. Transfections were carried twice every 
48 hours and migration assay was performed 24 hours after the second transfection. 
Cells were treated with mitomycin C for two hours to arrest cell cycle progression. 
After mitomycin C treatment cells were trypsinized and counted and seeded on Boyden 
chambers (transwell inserts of 8μm, 24-well plates, BD Biosciences). 8x104 cells were 
seeded with KBM growing medium (Lonza) without hrEGF. Media containing 10 
ng/ml of hrEGF (Lonza) was placed under the transwell inserts as chemoattractant to 
attract cells. Media without chemoattractant was placed under the transwell inserts in 
control experiments. Cells were allowed to migrate for 6 or 12 hours, after which the 
inserts were washed once with PBS, fixed with 4% PFA for 10 min, and cells were 
stained with DAPI. Cells from the upper side of the membrane were scratched off with 
a cotton bud and wash off with PBS several times. Cells on the bottom side of the 
membrane were imaged with a colony scan microscope. Cells were then quantified with 
the software CellProfiler. 
 
For motility analysis of human keratinocytes, 104 cells were seeded in 24-well 
ImageLock plates (Essen Instruments) in growing medium and kept for 26 hours at 
37°C in 5% CO2. Cell mobility was recorded with an automated IncuCyte microscope 
(Essen Instruments). Images were collected at 15 minutes intervals. 2D-cell migration 
was analyzed by using the MTracking function of ImageJ software. 2D-migration 
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tracks were generated by manually tracing the nucleus of each cell. Migrated distance 
was obtained by measuring the linear distance travelled between the first and last 
position (after 26 hours) of each tracked cell. 
 
tRNA sequencing library preparation 
Small RNA libraries were generated from snap-frozen skin papillomas from 4-weeks 
old mice. Four independent biological replicates were used. For tRNA library 
generation we followed the protocols as in59. Briefly total RNA was extracted using 
Trizol reagents (Invitrogen) and treated with DNase (Turbo DNase, Ambion). 
Ribosomal RNA was removed with Ribo-zero (Epicentre, Illumina). The remaining 
RNA fraction was size-selected using MirVana Isolation Kit (Invitrogen). Using 
MirVana RNA purification columns with two sequential filtration steps with different 
ethanol concentrations, an RNA fraction highly enriched in RNA species ≤ 200 nt was 
obtained. The small RNA fraction (approximately 200 ng) was first treated with 0.1 M 
Tris-HCl pH 9.0 and 1 mM EDTA for 30 min at 37°C to de-aminoacylate mature 
tRNAs and later T4-PNK (NEB) treated to ensure phosphorylated 5’ ends and 3’OH 
ends to proceed with RNA adapter ligation and library preparation. tRNA libraries were 
generated using TruSeq Small RNA Preparation Kit (Illumina). Briefly, 3’adenylated 
and 5’phosphorylated adapters suitable for Illumina RNA sequencing were ligated to 
the small RNA fraction. RNA was reverse-transcribed at 50ºC for 1 hour (SuperScript 
III cDNA synthesis kit, Invitrogen), followed by PCR amplification with Phusion DNA 
polymerase (Thermo scientific). All samples were multiplexed and sequenced in HiSeq 
platform (Illumina). 
 
Bisulphite sequencing library preparation 
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To generate bisulphite sequencing libraries RNA was prepared and bisulphite-treated 
as in63. Briefly RNA was extracted with Trizol reagents (Invitrogen) from snap-frozen 
skin tumours from 4-weeks old mice. Four independent biological replicates were used. 
Total RNA was extracted and DNase treated (Turbo DNase, Ambion). Samples were 
Ribo-zero treated (Epicentre, Illumina) to deplete them from rRNA. At least 1.5 g of 
the remaining RNA fraction was bisulphite-converted as follows: RNA was mixed in 
70  μl of 40% sodium bisulfite pH 5.0 and DNA protection buffer (EpiTect Bisulfite 
Kit, Qiagen). The reaction mixture was incubated for three to four cycles of 5 min at 
70ºC followed by 1 hour at 60ºC and then desalted with Micro Bio-spin 6 
chromatography columns (Bio-Rad). RNA was desulfonated by adding an equal 
volume of 1 M Tris (pH 9.0) to the reaction mixture and incubated for 1 h at 37°C, 
followed by ethanol precipitation. 2’,3’-cyclic phosphate and 5’-hydroxyl termini 
produced during the bisulphite/desulfonation reaction were end-repaired with T4 PNK 
(New England Biolabs). About 120 ng of bisulphite-converted RNA was used to 
generate Bisulphite-seq (BS-Seq) libraries. Because bisulphite treatment and 
desulfonation cleaves long RNAs into fragments of about 100 nt, we then used TruSeq 
Small RNA preparation kit (Illumina) to generate libraries suitable for Illumina 
sequencing as described in59. Briefly, RNA adapters suitable for Illumina sequencing 
were ligated to bisulphite-converted RNAs, reverse-transcribed at 50ºC for 1 hour with 
SuperScript III and 2 mM of each dNTP (SuperScript III cDNA synthesis kit, 
Invitrogen) followed by PCR amplification. All samples were multiplexed and 
sequenced on a HiSeq platform (Illumina). 
 
Preparation of Ribo-seq libraries 
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Two types of experiments were performed on mouse skin tumours (from K5-SOS mice) 
and human dermal fibroblasts samples from each set of conditions: ribosomal profiling 
(Ribo-seq) and mRNA-seq. All samples were sequenced using the HiSeq platform 
(Illumina). A minimum of three replicates was performed for each sample. Dermal 
fibroblasts were grown and infected when indicated as described in previous sections 
and with the constructs indicated in each experiment. For cells or tissue collection, none 
were pre-treated with cycloheximide, however cycloheximide was present in the 
following steps. Cells were washed with PBS (without cycloheximide) twice and lysis 
buffer (20 mM Tris-Cl (pH 7.4), 150 mM NaCl, 5 mM MgCl2, 1 mM DTT (Sigma), 
1% Triton X-100 (Sigma), 25 Units/ml of Turbo DNase I (Life Technologies) 
containing 100 g/ml of cycloheximide (Sigma) was added straight to the cells. 
Papillomas were dissected from the mice, snap-frozen in liquid nitrogen and later 
homogenized in lysis buffer containing 100 g/ml of cycloheximide. Cycloheximide 
was added to the lysis buffer to arrest translation elongation while the polysome fraction 
was being purified and mRNA fragments were recovered. We then proceeded with 
ribosome footprint purification without snap freezing the lysates as indicated in64. All 
the steps for cell or tissue lysis, nuclease footprinting, polysome fractionation, mRNA 
footprint purification and gel size-selection were performed as indicated in64. Briefly 
lysates were further triturated by passing them ten times through a 26-G needle. Nuclei 
and debris were removed by centrifugation at 13000 rpm for 10 min. Supernatant was 
digested with RNaseI (100U/l, Ambion) for 45 min at room temperature. Digestion 
was blocked with SuperaseIN (Ambion) and lysate was layered on a 1M sucrose 
cushion and separated by ultracentrifugation at 45000 rpm in a 70Ti rotor for 9 h at 
4°C. Pellets were resuspended in Qiazol and RNA fragments lower than 200 nt were 
extracted using miRNeasy kit (Qiagen) followed by ethanol precipitation. Size 
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selection of footprints with length of 26–34 nt was performed on 15% TBE-urea gel 
(Invitrogen). Footprints were 3’-dephosphorylated with T4 polynucleotide kinase 
(10U, NEB). From this step and to prepare libraries suitable for Illumina sequencing 
we slightly modified the original protocol64. mRNA footprints were then treated with 
Ribo-zero (Epicentre Illumina) to deplete rRNA. By using this extra step of rRNA 
depletion (together with the use of DNA oligos to deplete rDNA by subtractive 
hybridization in a later step) we were able to reduce rRNA contamination to only ~60% 
of all reads. mRNA footprints recovered from Ribo-zero were then prepared for Ribo-
seq using TruSeq Small RNA Preparation Kit (Illumina). Briefly, 3’adenylated and 
5’phosphorylated adapters suitable for Illumina RNA sequencing were ligated to the 
recovered mRNA fragments. RNA was reverse-transcribed at 50ºC for 1 hour 
(SuperScript III cDNA synthesis kit, Invitrogen), followed by rDNA depletion by 
subtractive hybridization (as indicated in the original protocol) using oligos listed in64 
and following the protocol recommendations. Recovered cDNAs were PCR-amplified 
with no more than 12 PCR cycles. All samples were multiplexed and sequenced in 
HiSeq platform (Illumina). 
 
Preparation of mRNA-seq libraries 
mRNA-seq libraries were generated from mouse skin tumours from 4-weeks old K5-
SOS/NSun2+/+ and K5-SOS/NSun2-/- mice, from mouse healthy back skin from 3.5-
4-weeks old NSun2+/+ or NSun2-/- mice (without tumours) and from human dermal 
fibroblasts (Nsun2+/+, NSun2+/- and NSun2-/-) growing in culture and infected when 
indicated. At least four replicates were performed for each sample. All samples were 
multiplexed and sequenced using the HiSeq platform (Illumina). Total RNA was 
extracted using Trizol (Invitrogen) from cells in culture or snap-frozen tissues. Total 
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RNA was DNase (Turbo DNase, Ambion) and Ribo-zero (Epicentre, Illumina) treated. 
rRNA-depleted RNA was used to generate mRNA-seq libraries using NEXTflex 
Directional RNA-seq Kit V2 (Illumina). All samples were multiplexed and sequenced 
in HiSeq platform (Illumina). 
 
Next-generation sequence data analyses 
For all data analyses, FastQC was used for the initial assessment of the quality and basic 
processing of the reads (http://www.bioinformatics.babraham.ac.uk/projects/fastqc). 
Sequencing adapters were trimmed from the 5’ and the 3’ ends of the reads using 
cutadapt (v1.4.2; https://pypi.python.org/pypi/cutadapt/1.4.2). 
 
RNA bisulphite(BS)-seq analysis 
To determine RNA methylation levels in mouse K5-SOS tumours, two complementary 
protocols for the analysis of BS-seq data were used:  
 
(1) Alignment to the genome. BS-seq reads were aligned to mouse reference genome 
(GRCm38/mm10) with Bismark 
(http://www.bioinformatics.babraham.ac.uk/projects/bismark; version 0.13.1; options: 
‘--directional –n 0 –l 40’). Methylation levels for all cytosines with at least coverage of 
≥ 5 reads (5X coverage) in both K5-SOS/NSun2+/+ and K5-SOS/NSun2-/- tumour 
samples were inferred with Bismark ‘methylation_extractor’. Cytosine positions 
displaying a difference in RNA methylation of at least 10% between K5-
SOS/NSun2+/+ and K5-SOS/NSun2-/- tumour samples were extracted based on the 
ENSEMBL (GRCm38, Release 74; www.ensembl.org/info/data/ftp) transcript 
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annotations and tRNA gene predictions in the mouse (GRCm38/mm10) reference 
genome obtained from GtRNAdb (http://lowelab.ucsc.edu/GtRNAdb).  
 
(2) Alignment to representative transcripts. Sequences for ENSEMBL transcripts and 
tRNAs were extracted in FASTA format. All transcript isoforms were considered, and 
in addition the longest gene at full length including introns was retained as a 
representative sequence to identify RNA methylation sites in introns. C’s were 
converted to T’s in the reference transcript sequences, and in the processed BS-seq 
reads. Alignment of converted BS-seq reads against converted transcript sequences 
were performed using bowtie (version 1.1.1; bowtie-bio.sourceforge.net; options ‘–m 
500 –v 2 –a –best –strata’). Following alignments, the reads that aligned in sense 
direction were obtained, and the original transcript sequences and reads were used to 
compile RNA methylation (C/(C+T) levels considering only cytosines with at least 5X 
coverage. Heatmaps displaying either C or T in the aligned reads at each cytosine 
position were generated using custom PERL scripts and matrix2png 
(www.chibi.ubc.ca/matrix2png/) for visualization. Cytosine positions on the heatmaps 
were reported relative to the annotated transcriptional start sites of the transcripts.  
 
tRNA-seq data analysis 
The abundance of tRNA fragments was determined according to a previously published 
protocol described in59. Adapter-trimmed tRNA-seq reads (> 20 nt and < 200 nt in 
length) were mapped to the mouse reference genome (GRCm38/mm10) using bowtie 
(version 1.1.1; bowtie-bio.sourceforge.net; options ‘-m1 –v2 –a –best --strata’) 
considering only reads that map uniquely to the genome. To account for the 
polymerization of CCA-3’-ends onto mature tRNAs, the remaining unmapped reads 
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were trimmed of CCA[CCA] ends and realigned using the same options. Annotations 
were conducted based on tRNA genes predicted for the mouse reference genome 
(GRCm38/mm10) and downloaded from GtRNAdb 
(http://lowelab.ucsc.edu/GtRNAdb). Reads that exceeded the annotated tRNA gene 
start or end by more than 10% were discarded. All distinct reads, which were shorter 
than 90% of the annotated tRNA gene length, were considered as tRNA fragments. 
Counts per fragments were normalized, and the differential abundances of fragments 
processed from the 5’ or 3’ halves of the tRNAs were statistically evaluated using the 
R/Bioconductor DESeq package 
(http://bioconductor.org/packages/release/bioc/html/DESeq.html). tRNA fragment 
abundances are given by log2(DESeq-normalized counts). 
 
mRNA-seq and Ribo-seq data analyses 
Ribosome profiling data was processed following established protocols65: The first 5' 
base of the adapter-trimmed Ribo-seq reads was removed, as this is usually an artefact 
of reverse transcription64. For removing abundant contamination from digested rRNA 
present in the libraries, the reads were aligned to a collection of rRNA sequences 
obtained from Genbank and UCSC using bowtie (options: ‘-n 2 --seedlen=23’). Reads 
aligning to rRNA were discarded, with the average rRNA contamination per sample 
being around 60%. Only reads with at least 24 nt and less than 30 nt length were 
retained in accordance with the observed length distribution of ribosome footprints66. 
 
Both the Ribo-seq and mRNA-seq reads were aligned to the human (GRCh37/hg19) 
and to the mouse (GRCm38/mm10) reference genomes using Tophat2 (version: 2.1; 
options: ‘--read-mismatch 1(2) --max-multihits 1 –GTF’) guided by ENSEMBL gene 
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models (release 76), allowing for two mismatches per read for human and one mismatch 
per read for mouse, and unique alignments only.  
 
To determine mRNA abundance, mRNA-seq read counts for the full transcript were 
calculated using htseq-count (http://www-huber.embl.de/HTSeq/doc/overview.html), 
data sets were normalized, and the statistical significance of differential expression was 
evaluated by using the R/Bioconductor DESeq2 package 
(https://bioconductor.org/packages/release/bioc/html/DESeq2.html). 
  
To evaluate differences in translation, the following additional Ribo-seq data analyses 
and normalizations were performed:  
 
(1) Alignment to representative regions. Coding sequences (CDS) and 5’UTRs were 
downloaded from ENSEMBL including ‘protein_coding’ and ‘nonsense-mediated 
decay’ types of transcripts. Intron sequences were excluded.  Ribo-seq reads, which 
uniquely aligned to the genome in the initial alignment step using Tophat2, were 
aligned to 5’UTR or CDS sequences using bowtie (options: ‘-m 1000 –v1’) allowing 
for multiple mappings to overlapping regions of the same gene.  
 
(2) Statistical analysis of differential ribosome footprint densities and normalization. 
In concordance with other studies performed in yeast or mammalian cells67,68, we 
observed a characteristic 5’ ‘ramp’ of ribosome footprints at the translation start site of 
the CDS for our samples. It has been suggested that these excess footprints are a result 
of cycloheximide-inflicted accumulation of ribosomes64. To prevent any artifactual bias 
in our analysis, we followed the instructions for normalization in69. Read counts were 
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extracted that aligned either to (1) all full-length CDS (see Supplementary tables 6-10) 
or to (2) all CDS sequences without the initial 150 nt (50 codons) corresponding to the 
ribosomal ramp (see Supplementary table 5 and Fig. 5e). For both data sets, statistical 
tests were performed with the R/Bioconductor DESeq package. The two sets of DESeq 
scaling factors were subsequently used for normalization of data sets. The DESeq-
normalized counts for all regions were divided by their length in kB to define ribosome 
footprint densities. 
 
(3) Analysis of ribosome footprint densities at 5’UTRs. Reads that mapped uniquely to 
the genome by using Tophat2, were mapped to the 5’UTR sequences with bowtie 
(options: ‘-m 1000 –v1’). Differences in ribosome footprint densities on the full 
5’UTRs were evaluated by using the DESeq scaling factors obtained from the analysis 
of CDS (Supplementary tables 7-9) for normalization, and DESeq to perform statistical 
tests for differences. DESeq-normalized counts for 5’UTR were divided by their length 
in kB to define ribosome footprint densities. 
 
(4) Analysis of triplet periodicity. Footprints of length 28 nt were extracted, since they 
report with high precision on the position of the ribosome66. The frequencies of the 5’-
starts of the footprints, which were aligned close to the annotated translation initiation 
sites, were aggregated for all genes. 
 
(5) Heat map analysis. For the heat map analysis in (Extended Data Fig. 8d) we 
specifically selected the 43,625 representative and well-annotated protein-coding 
transcripts from GENECODE that overlap ENSEMBL transcript structures 
(“ensembl_havana”). The positions of the start codons were obtained from the 
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ENSEMBL “Gene sets” gtf file (http://www.ensembl.org/info/data/ftp/index.html). 
Heat maps of ribosome footprint densities (RPKMs) were generated for regions +/- 
1500 nt around the start codon by using ngsplot (https://github.com/shenlab-
sinai/ngsplot).   
 
If not indicated otherwise Gene ontology categories represent GOTERM_BP_FAT in 
DAVID (david.ncifcrf.gov).  
 
Protein extraction and western blot analysis 
To extract proteins from squamous tumours, samples were snap-frozen in liquid 
nitrogen, transferred to lysis buffer (1% NP-40, 200 mM NaCl, 25 mM Tris-HCl, pH 
8, 1 mM DTT) including protease inhibitor cocktail (Roche) and homogenized and 
cleared by centrifugation at 13,000 rpm. To extract proteins from cells in culture, the 
same lysis buffer was added to the plate and scratched the cells from the plate surface, 
left lysing for 20 min in ice and cleared by centrifugation. Total protein quantification 
was performed using BCA Protein Assay (Thermo fisher). Equal amounts of protein 
were run in polyacrylamide gels. Western blotting was performed as described in54. The 
following primary antibodies were used for western blot analyses: anti-PSAT (Protein 
Tech Group, 10501-1-AP), anti-THBS1 (Santa Cruz, sc-65612), anti-Sesn2 (Protein 
Tech Group, 10795-1-AP), anti-Calreticulin (Abcam, ab2907), anti-INHBA (Sigma-
Aldrich, SAB1408593), anti-NSun2 (Aviva Systems Biology, ARP48811_P050), anti-
Keratin 19 (Abcam, ab52625), anti-CD44 (IM7, Biolegend, 103004), anti-Bcl10 
(H197, Santa Cruz, sc-5611), anti-Semaphorin3A (SEMA3A) (Abcam, ab23393), anti-
PSMD11 (Abcam, ab66346), anti-SPHK1 (Cell Signaling, 3297), anti-APTX (Abcam, 
ab31841), anti-Slug (Cell Signaling, 9585P), anti-Snail (Abcam, ab180714), anti-
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SOD2 (Abcam, ab13534), anti-CLSPN (Bethyl Laboratories, A300-266A), anti-ZAK 
(Sigma, HPA017205), anti-CHAF1B or CAF1 p60 (Abcam, ab180371 -
Tubulin (Abcam, ab15246) was used as a loading control. Band intensity was quantified 
with Image J software. 
 
Statistical methods 
Group data are always represented by mean and standard deviation, unless otherwise 
indicated in figure legends. To test statistical significance between samples unpaired 
two-tailed Student’s t-tests were used. To test for significance of populations (i.e. stem 
cells versus differentiated cell populations) within one sample (mouse) we used the 
paired Student’s test. To analyze the differences among group means we used ANOVA. 
Violin plots were created using the vioplot package (https://cran.r-
project.org/package=vioplot) in R. The outline of the violin plots represents the kernel 
probability density of the data at different values. Violin plots include a marker for the 
median of the data and a box indicating the interquartile range70. Boxplots were created 
with Prism 6 software. The box extends from the 25th to 75th percentiles and the line 
in the middle of the box is plotted at the median. The whiskers show minimum to 
maximum. Scatter plots, linear regression lines and coefficient of correlation (r2) were 
calculated using Prism 6 software by computing non-parametric Spearman correlation 
and two-tailed P values.  
 
Sample sizing and collection 
At least three samples were used per experimental group and condition. The number of 
samples used in each experiment is indicated in all main figures, in legends of Extended 
Data figures and in Source Data files.  
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Samples and experimental animals were randomly assigned to experimental groups. 
Sample collection was also assigned randomly. Experimental procedures in vitro, 
sample collection and data analysis were performed blindly whenever possible. 
Whenever possible automated quantifications were performed using the appropriate 
software. Most animal procedures (i.e. mouse treatments) were performed blindly by 
individuals unaware of the experimental design. 
 
Accession codes 
All human sequencing data are available on dbGAP (phs000645.v2.p1). All mouse 
sequencing data are available on GEO under the accession number GSE72067. 
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